Title | High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program. |
Publication Type | Journal Article |
Year of Publication | 2019 |
Authors | Labbé DP, Zadra G, Yang M, Reyes JM, Lin CY, Cacciatore S, Ebot EM, Creech AL, Giunchi F, Fiorentino M, Elfandy H, Syamala S, Karoly ED, Alshalalfa M, Erho N, Ross A, Schaeffer EM, Gibb EA, Takhar M, Den RB, Lehrer J, R Karnes J, Freedland SJ, Davicioni E, Spratt DE, Ellis L, Jaffe JD, DʼAmico AV, Kantoff PW, Bradner JE, Mucci LA, Chavarro JE, Loda M, Brown M |
Journal | Nat Commun |
Volume | 10 |
Issue | 1 |
Pagination | 4358 |
Date Published | 2019 09 25 |
ISSN | 2041-1723 |
Keywords | Aged, Animals, Cell Line, Tumor, Cell Proliferation, Diet, High-Fat, Disease Progression, Gene Expression Regulation, Neoplastic, Humans, Male, Metabolome, Mice, Transgenic, Middle Aged, Prostatic Neoplasms, Proto-Oncogene Proteins c-myc, Tumor Burden |
Abstract | Systemic metabolic alterations associated with increased consumption of saturated fat and obesity are linked with increased risk of prostate cancer progression and mortality, but the molecular underpinnings of this association are poorly understood. Here, we demonstrate in a murine prostate cancer model, that high-fat diet (HFD) enhances the MYC transcriptional program through metabolic alterations that favour histone H4K20 hypomethylation at the promoter regions of MYC regulated genes, leading to increased cellular proliferation and tumour burden. Saturated fat intake (SFI) is also associated with an enhanced MYC transcriptional signature in prostate cancer patients. The SFI-induced MYC signature independently predicts prostate cancer progression and death. Finally, switching from a high-fat to a low-fat diet, attenuates the MYC transcriptional program in mice. Our findings suggest that in primary prostate cancer, dietary SFI contributes to tumour progression by mimicking MYC over expression, setting the stage for therapeutic approaches involving changes to the diet. |
DOI | 10.1038/s41467-019-12298-z |
Alternate Journal | Nat Commun |
PubMed ID | 31554818 |
PubMed Central ID | PMC6761092 |
Grant List | P01 CA163227 / CA / NCI NIH HHS / United States P30 CA008748 / CA / NCI NIH HHS / United States P50 CA090381 / CA / NCI NIH HHS / United States |
Related Lab:
Related Faculty:
Massimo Loda, M.D.